Adel Boueiz1,2, Sharon M Lutz3, Michael H Cho1,2, Craig P Hersh1,2, Russell P Bowler4, George R Washko2, Eitan Halper-Stromberg4, Per Bakke5, Amund Gulsvik5, Nan M Laird6, Terri H Beaty7, Harvey O Coxson8, James D Crapo4, Edwin K Silverman1,2, Peter J Castaldi1,9, Dawn L DeMeo1,2. 1. 1 Channing Division of Network Medicine. 2. 2 Pulmonary and Critical Care Division, Department of Medicine, and. 3. 3 Department of Biostatistics, Colorado School of Public Health, University of Colorado, Aurora, Colorado. 4. 4 Division of Pulmonary Medicine, Department of Medicine, National Jewish Health, Denver, Colorado. 5. 5 Department of Clinical Science, University of Bergen, Bergen, Norway. 6. 6 Harvard School of Public Health, Boston, Massachusetts. 7. 7 Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; and. 8. 8 Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada. 9. 9 Division of General Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Abstract
RATIONALE: Emphysema has considerable variability in the severity and distribution of parenchymal destruction throughout the lungs. Upper lobe-predominant emphysema has emerged as an important predictor of response to lung volume reduction surgery. Yet, aside from alpha-1 antitrypsin deficiency, the genetic determinants of emphysema distribution remain largely unknown. OBJECTIVES: To identify the genetic influences of emphysema distribution in non-alpha-1 antitrypsin-deficient smokers. METHODS: A total of 11,532 subjects with complete genotype and computed tomography densitometry data in the COPDGene (Genetic Epidemiology of Chronic Obstructive Pulmonary Disease [COPD]; non-Hispanic white and African American), ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints), and GenKOLS (Genetics of Chronic Obstructive Lung Disease) studies were analyzed. Two computed tomography scan emphysema distribution measures (difference between upper-third and lower-third emphysema; ratio of upper-third to lower-third emphysema) were tested for genetic associations in all study subjects. Separate analyses in each study population were followed by a fixed effect metaanalysis. Single-nucleotide polymorphism-, gene-, and pathway-based approaches were used. In silico functional evaluation was also performed. MEASUREMENTS AND MAIN RESULTS: We identified five loci associated with emphysema distribution at genome-wide significance. These loci included two previously reported associations with COPD susceptibility (4q31 near HHIP and 15q25 near CHRNA5) and three new associations near SOWAHB, TRAPPC9, and KIAA1462. Gene set analysis and in silico functional evaluation revealed pathways and cell types that may potentially contribute to the pathogenesis of emphysema distribution. CONCLUSIONS: This multicohort genome-wide association study identified new genomic loci associated with differential emphysematous destruction throughout the lungs. These findings may point to new biologic pathways on which to expand diagnostic and therapeutic approaches in chronic obstructive pulmonary disease. Clinical trial registered with www.clinicaltrials.gov (NCT 00608764).
RATIONALE: Emphysema has considerable variability in the severity and distribution of parenchymal destruction throughout the lungs. Upper lobe-predominant emphysema has emerged as an important predictor of response to lung volume reduction surgery. Yet, aside from alpha-1 antitrypsin deficiency, the genetic determinants of emphysema distribution remain largely unknown. OBJECTIVES: To identify the genetic influences of emphysema distribution in non-alpha-1 antitrypsin-deficient smokers. METHODS: A total of 11,532 subjects with complete genotype and computed tomography densitometry data in the COPDGene (Genetic Epidemiology of Chronic Obstructive Pulmonary Disease [COPD]; non-Hispanic white and African American), ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints), and GenKOLS (Genetics of Chronic Obstructive Lung Disease) studies were analyzed. Two computed tomography scan emphysema distribution measures (difference between upper-third and lower-third emphysema; ratio of upper-third to lower-third emphysema) were tested for genetic associations in all study subjects. Separate analyses in each study population were followed by a fixed effect metaanalysis. Single-nucleotide polymorphism-, gene-, and pathway-based approaches were used. In silico functional evaluation was also performed. MEASUREMENTS AND MAIN RESULTS: We identified five loci associated with emphysema distribution at genome-wide significance. These loci included two previously reported associations with COPD susceptibility (4q31 near HHIP and 15q25 near CHRNA5) and three new associations near SOWAHB, TRAPPC9, and KIAA1462. Gene set analysis and in silico functional evaluation revealed pathways and cell types that may potentially contribute to the pathogenesis of emphysema distribution. CONCLUSIONS: This multicohort genome-wide association study identified new genomic loci associated with differential emphysematous destruction throughout the lungs. These findings may point to new biologic pathways on which to expand diagnostic and therapeutic approaches in chronic obstructive pulmonary disease. Clinical trial registered with www.clinicaltrials.gov (NCT 00608764).
Authors: Ani Manichaikul; Eric A Hoffman; Joanna Smolonska; Wei Gao; Michael H Cho; Heather Baumhauer; Matthew Budoff; John H M Austin; George R Washko; J Jeffrey Carr; Joel D Kaufman; Tess Pottinger; Charles A Powell; Cisca Wijmenga; Pieter Zanen; Harry J M Groen; Dirkje S Postma; Adam Wanner; Farshid N Rouhani; Mark L Brantly; Rhea Powell; Benjamin M Smith; Dan Rabinowitz; Leslie J Raffel; Karen D Hinckley Stukovsky; James D Crapo; Terri H Beaty; John E Hokanson; Edwin K Silverman; Josée Dupuis; George T O'Connor; H Marike Boezen; Stephen S Rich; R Graham Barr Journal: Am J Respir Crit Care Med Date: 2014-02-15 Impact factor: 21.405
Authors: A Di Stefano; G Caramori; T Oates; A Capelli; M Lusuardi; I Gnemmi; F Ioli; K F Chung; C F Donner; P J Barnes; I M Adcock Journal: Eur Respir J Date: 2002-09 Impact factor: 16.671
Authors: Peter J Castaldi; Michael H Cho; Xiaobo Zhou; Weiliang Qiu; Michael Mcgeachie; Bartolome Celli; Per Bakke; Amund Gulsvik; David A Lomas; James D Crapo; Terri H Beaty; Stephen Rennard; Benjamin Harshfield; Christoph Lange; Dave Singh; Ruth Tal-Singer; John H Riley; John Quackenbush; Benjamin A Raby; Vincent J Carey; Edwin K Silverman; Craig P Hersh Journal: Hum Mol Genet Date: 2014-10-14 Impact factor: 6.150
Authors: Weiliang Qiu; Michael H Cho; John H Riley; Wayne H Anderson; Dave Singh; Per Bakke; Amund Gulsvik; Augusto A Litonjua; David A Lomas; James D Crapo; Terri H Beaty; Bartolome R Celli; Stephen Rennard; Ruth Tal-Singer; Steven M Fox; Edwin K Silverman; Craig P Hersh Journal: PLoS One Date: 2011-09-16 Impact factor: 3.240
Authors: Joshua D Campbell; John E McDonough; Julie E Zeskind; Tillie L Hackett; Dmitri V Pechkovsky; Corry-Anke Brandsma; Masaru Suzuki; John V Gosselink; Gang Liu; Yuriy O Alekseyev; Ji Xiao; Xiaohui Zhang; Shizu Hayashi; Joel D Cooper; Wim Timens; Dirkje S Postma; Darryl A Knight; Marc E Lenburg; James C Hogg; Avrum Spira Journal: Genome Med Date: 2012-08-31 Impact factor: 11.117
Authors: Alireza Sadeghnejad; Jill A Ohar; Siqun L Zheng; David A Sterling; Gregory A Hawkins; Deborah A Meyers; Eugene R Bleecker Journal: Respir Res Date: 2009-03-12
Authors: Adel Boueiz; Yale Chang; Michael H Cho; George R Washko; Raul San José Estépar; Russell P Bowler; James D Crapo; Dawn L DeMeo; Jennifer G Dy; Edwin K Silverman; Peter J Castaldi Journal: Chest Date: 2017-09-21 Impact factor: 9.410
Authors: William Z Zhang; Kazunori Gomi; Seyed Babak Mahjour; Fernando J Martinez; Renat Shaykhiev Journal: Am J Respir Crit Care Med Date: 2018-06-15 Impact factor: 21.405
Authors: Peter J Castaldi; Adel Boueiz; Jeong Yun; Raul San Jose Estepar; James C Ross; George Washko; Michael H Cho; Craig P Hersh; Gregory L Kinney; Kendra A Young; Elizabeth A Regan; David A Lynch; Gerald J Criner; Jennifer G Dy; Stephen I Rennard; Richard Casaburi; Barry J Make; James Crapo; Edwin K Silverman; John E Hokanson Journal: Chest Date: 2019-12-28 Impact factor: 9.410
Authors: Margaret F Ragland; Christopher J Benway; Sharon M Lutz; Russell P Bowler; Julian Hecker; John E Hokanson; James D Crapo; Peter J Castaldi; Dawn L DeMeo; Craig P Hersh; Brian D Hobbs; Christoph Lange; Terri H Beaty; Michael H Cho; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2019-09-15 Impact factor: 21.405
Authors: Monica H Wojcik; Nikkola Carmichael; Frederick R Bieber; Daniel C Wiener; Rachna Madan; Barbara R Pober; Benjamin A Raby Journal: Am J Med Genet A Date: 2017-06-02 Impact factor: 2.802
Authors: Julian Hecker; Ingo Ruczinski; Michael H Cho; Edwin K Silverman; Brent Coull; Christoph Lange Journal: Genet Epidemiol Date: 2019-11-11 Impact factor: 2.135
Authors: Adel Boueiz; Betty Pham; Robert Chase; Andrew Lamb; Sool Lee; Zun Zar Chi Naing; Michael H Cho; Margaret M Parker; Phuwanat Sakornsakolpat; Craig P Hersh; James D Crapo; Andrew B Stergachis; Ruth Tal-Singer; Dawn L DeMeo; Edwin K Silverman; Xiaobo Zhou; Peter J Castaldi Journal: Am J Respir Cell Mol Biol Date: 2019-04 Impact factor: 6.914
Authors: Donna K Arnett; Ramachandran S Vasan; Matthew Nayor; Li Shen; Gary M Hunninghake; Peter Kochunov; R Graham Barr; David A Bluemke; Ulrich Broeckel; Peter Caravan; Susan Cheng; Paul S de Vries; Udo Hoffmann; Márton Kolossváry; Huiqing Li; James Luo; Elizabeth M McNally; George Thanassoulis Journal: Circ Cardiovasc Imaging Date: 2021-08-13 Impact factor: 8.589